Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

80.32 +0.37 (+0.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,931,624
Open 79.16
Bid (Size) 80.20 (2)
Ask (Size) 80.50 (1)
Prev. Close 79.95
Today's Range 78.76 - 81.82
52wk Range 62.55 - 217.25
Shares Outstanding 381,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
The big biotech's shares have been on the rise this year. 
Via The Motley Fool
Moderna's Options Frenzy: What You Need to Know
Via Benzinga

Performance

YTD
-55.13%
-55.13%
1 Month
+14.66%
+14.66%
3 Month
-24.08%
-24.08%
6 Month
-38.21%
-38.21%
1 Year
-51.36%
-51.36%

More News

Read More
7 F-Rated Stocks to Sell in December
Via InvestorPlace
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
Analyst Expectations for Moderna's Future
Via Benzinga
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
Via ACCESSWIRE
2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
Via Benzinga
Topics Stocks
Exposures US Equities
3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year
Via The Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
Via The Motley Fool
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Big Players' Recent Trades in MRNA Options
Via Benzinga
Big Players' Recent Trades in MRNA Options
Via Benzinga
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
Via Talk Markets
Topics Lawsuit
Exposures COVID-19 Financial Legal
Upwork underscores the strength of the AI gig economy
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.
Via InvestorPlace
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
Peering Into Moderna's Recent Short Interest
Via Benzinga
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!
Via InvestorPlace
Topics Earnings Stocks
Exposures Financial US Equities
Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.